Generic Medicine Info
Hypersensitivity, malignancy. Direct application to the cornea, reduction of swelling of bites or stings. Inj into or around infected area. IV admin; unexplained premature labour.
Special Precautions
Impaired renal function. Infants, elderly. Patients with infections. Pregnancy, lactation.
Adverse Reactions
Urticaria, occasional severe allergy.
Potentially Fatal: Hypersensitivity and anaphylaxis.
Drug Interactions
Action potentiated by urokinase especially in the treatment of MI. May increase absorption and toxicity of local anaesthetics. Heparin, salicylates and NSAIDs may inhibit the spreading action and efficacy of hyaluronidase.
CIMS Class
ATC Classification
B06AA03 - hyaluronidase ; Belongs to the class of enzymes used as hematological agent.
Disclaimer: This information is independently developed by CIMS based on hyaluronidase from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in